News Archive

/News Archive/

Xeltis data shortlisted at EACTS Techno-College Innovation Award

2019-02-14T11:30:53+00:00October 19th, 2018|News|

An abstract on Xeltis clinical data has been shortlisted as one of five finalists at the EACTS Techno-College Innovation Award. Professor Tomasz Mroczek from the Children’s University Hospital, Krakow, Poland will present 1-year Xeltis data on the “First clinical experience [...]

Xeltis’ aortic valve one of highest peer-review oral abstracts at TCT

2019-02-14T11:33:48+00:00September 18th, 2018|News|

Initial in vivo experience on Xeltis’ restorative aortic valve will feature as one of the highest peer-reviewed oral abstracts of TCT 2018. Professor Christian Spaulding, Chief, Interventional Cardiology, European Hospital Georges Pompidou, Paris (F), will present long-term pre-clinical on Xeltis’ [...]

Xeltis’ restorative technology featured at ISACB

2019-02-14T11:34:45+00:00September 14th, 2018|News|

Preclinical data on Xeltis’ restorative heart valve technology will feature at the 16th International Society of Applied Cardiovascular Biology (ISACB) Biennial meeting. Professor Frederick J. Schoen from Harvard Medical School will present 1-year preclinical data outlining the capability of Xeltis [...]

The Children’s Hospital Colorado joins the Xplore-2 trial

2019-02-14T11:35:40+00:00July 5th, 2018|News|

The Children’s Hospital Colorado has joined other prominent U.S. pediatric centers in the Xplore-2 clinical research study, the first medical center in the Mountain States to take part in the trial. The medical institutions already enrolling patients as part of the [...]

Children’s Hospital Los Angeles joins the Xplore-2 Study

2019-02-11T17:27:22+00:00June 22nd, 2018|Latest News|

Children’s Hospital Los Angeles (CHLA) recently joined other prominent U.S. pediatric centers in the Xplore-2 clinical research study. The medical institutions that may enroll patients in the Xplore-2 Early Feasibility Study also include: Boston Children’s Hospital, Children’s Healthcare of [...]

Xeltis restorative technology for aortic valves at ISMICS

2018-06-13T09:55:09+00:00June 13th, 2018|News|

The potential for Xeltis’ restorative technology in aortic valves will be showcased at the International Society for Minimally Invasive Cardiothoracic Surgery meeting in Vancouver on June 13-16.    Doctor Gregory Fontana, CardioVascular Institute Los Robles Hospital, Thousand Oaks, California, will [...]

Preliminary Xplore-1 data show promise at ECHSA

2018-06-01T15:20:20+00:00June 1st, 2018|Latest News|

Preliminary one-year data from the Xplore-1 clinical trial have shown that Xeltis’ restorative pulmonary heart valve has potential for use in RVOT reconstruction. In a presentation at the ECHSA meeting in Cascais, Portugal, trial investigator Professor Tomasz Mroczek from the [...]

Preliminary Xplore-1 data at ECHSA

2018-05-30T00:15:47+00:00May 30th, 2018|Latest News|

Preliminary one-year data from the Xplore-1 clinical trial, evaluating Xeltis’ restorative pulmonary heart, valve will be presented for the first time at the ECHSA meeting in Cascais, Portugal. Trial investigator Professor Tomasz Mroczek from the Children’s University Hospital, Krakow, Poland, [...]

Xeltis’ aortic valve program in focus at EuroPCR

2018-05-22T07:30:57+00:00May 22nd, 2018|Latest News|

Xeltis’ restorative heart valves are the focus of two presentations at the EuroPCR meeting in Paris. Prof. Martin B. Leon, Columbia University Medical Center, and Prof. Patrick Serruys, Imperial College London, are providing an outline on the developments of Xeltis’ [...]

Load More Posts